Wikisage, the free encyclopedia of the second generation, is digital heritage
Primidone: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
mNo edit summary |
||
Line 8: | Line 8: | ||
File:Primidone_ball-and-stick.png | File:Primidone_ball-and-stick.png | ||
</gallery> | </gallery> | ||
http://www.whocc.no/atc_ddd_index/?code=N03AA03 | |||
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5 | |||
|colspan=2| <center> | |||
: [[wikipedia:primidone|primidone]] | |||
<ref> | |||
http://www.whocc.no/atc_ddd_index/?code=N03AA03</ref></center> | |||
|} | |||
<ref>[https://www.ncbi.nlm.nih.gov/pubmed/27843822 Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner]</ref> | <ref>[https://www.ncbi.nlm.nih.gov/pubmed/27843822 Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner]</ref> | ||
Revision as of 17:37, 25 November 2016
Primidone is an anticonvulsant that is metabolized to phenylethylmalonamide (PEMA) and phenobarbital[1], historical considered a prodrug of phenobarbital, nevertheless it is superior against tremor [2] [3] Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner
ATC
Links
Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs
Factors Associated with Ordering Laboratory Monitoring of High-Risk Medications
Notes
- ↑ Practice Parameter:Therapies for essential tremor Report of the Quality Standards Subcommittee of the American Academy of Neurology
- ↑ Essential Tremor: What We Can Learn from Current Pharmacotherapy
- ↑ Molecular Mechanisms of Antiseizure Drug Activity at GABAA Receptors
- ↑ http://www.whocc.no/atc_ddd_index/?code=N03AA03
- ↑ Chronic high-cumulative doses have shown to increase the fracture risk in a dose-dependent manner